Search Results 2141-2150 of 19663 for Hemoglobin

  1. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    Hemoglobin < 8.0 g/dL (80 g/L);; White blood cell count < 3,500/mm^3 (3.5 × 10^9 /L):; Absolute neutrophil count < 1,000/mm^3 (1.0 × 10^9 /L);; Absolute ...

  2. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. A Study to Measure Elbow and Ankle Range-of-Motion via Teleconferencing. Jacksonville ...

  3. Orthopedic Surgery - Clinical trials

    ... hemoglobin levels, 90-day complications, readmission and reoperation. A Study to Measure Elbow and Ankle Range-of-Motion via Teleconferencing. Jacksonville ...

  4. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    Hemoglobin < 8 g/dL;; Absolute neutrophil count < 1500/µL;; Absolute lymphocyte count < 500/µL. Participating Mayo Clinic locations. Study statuses change ...

  5. Eligibility and FAQs - Mayo Clinic

    Brief health checkup. Before you give blood, a healthcare professional checks your temperature, blood pressure and pulse and does a hemoglobin test to make sure ...

  6. Publications - Mark A. Bendel, M.D. - Mayo Clinic

    Preoperative hemoglobin A1c and perioperative blood glucose in patients with diabetes mellitus undergoing spinal cord stimulation surgery: A literature ...

  7. Medical Laboratory Science Program (Florida and Minnesota) - Curriculum

    Laboratory sessions focus on theory and application of hematology procedures, including analysis of peripheral blood for red cell mass, hemoglobin content ...

  8. In Clinical Trials - Mayo Clinic Research

    ... hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous ...

  9. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (≥ 90 g/L) without transfusion within 2 weeks before screening laboratory sample collection. Alanine aminotransferase (ALT), aspartate ...

  10. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...